Oral Cancer: Page 58

Reolysin may aid head/neck cancer chemo patients
By DrBicuspid.com staff writers
Reolysin, a drug developed by Oncolytics Biotech to boost the effects of standard chemotherapy drugs, has shown initial positive results in a clinical study of patients with head and neck cancer.
December 30, 2012
New research reveals genetic mutations of head/neck cancer
By DrBicuspid.com staff writers
New findings regarding the genetic mutations that cause head and neck cancer may lead to new therapies, according to collaborative research presented in November at the 2012 Chemotherapy Foundation Symposium in New York City.
December 25, 2012
Oral Cancer Foundation wins nonprofit award
By DrBicuspid.com staff writers
The Oral Cancer Foundation has been honored as the 2012 top-rated nonprofit organization by GreatNonprofits.
December 23, 2012
LED Medical raises $1.2M through share offering
By DrBicuspid.com staff writers
LED Medical Diagnostics, parent company of LED Dental, has raised $1.2 million for product development, inventory, and working capital through another private placement of company shares.
December 23, 2012
Perio treatment may lower risk of preterm birth
By Rabia Mughal
A new systematic review in the Journal of Periodontology has found that pregnant women who are at high risk for preterm birth and have periodontal disease may be able to lower their risk by getting scaling and root planing treatment.
December 23, 2012
2009 05 19 09 23 26 920 Pregnant Woman 70
Australian research grant targets oral cancer
By DrBicuspid.com staff writers
Hans Zoellner, BDS, PhD, an associate professor and head of oral pathology at the University of Sydney, has been awarded the 2012 Australian Dental Industry Association Research Grant.
December 20, 2012
Smokeless tobacco sales in Calif. nearly triple
By DrBicuspid.com staff writers
Sales of smokeless tobacco products have risen dramatically in California over the last decade, according to a report by the California Department of Public Health.
December 17, 2012
Dentist: Coffee's dental benefits need more research
By DrBicuspid.com staff writers
A recent study from the American Cancer Society that associates heavy coffee drinking with a reduced risk of death from oral cancer is being questioned by a dentist who specializes in oncology.
December 17, 2012
CDA journal spotlights work of young researchers
By DrBicuspid.com staff writers
The December issue of the Journal of the California Dental Association spotlights the research work of up and coming investigators in the state's dental schools, the California Dental Association (CDA) announced.
December 13, 2012
HNC treatment location affects patient morbidity
By DrBicuspid.com staff writers
Patients with head and neck cancer (HNC) receiving radiation treatment at an academic center have a higher survival rate than those receiving treatment at a community center, according to a new study in Otolaryngology -- Head and Neck Surgery.
December 11, 2012
Dose study disputes bitewing-meningioma link
By Kathy Kincade
A study published in Cancer earlier this year prompted outcry in the dental community because it claimed to have found a link between exposure to dental bitewings and increased risk of developing a certain type of brain tumor. But a new study that provides in-depth organ dose data following exposure to bitewing x-rays calls those findings into question.
December 11, 2012
2008 09 05 12 47 03 795 Radiation 70
Caffeinated coffee may reduce oral cancer risk
By DrBicuspid.com staff writers
A new American Cancer Society study finds a strong inverse association between caffeinated coffee intake and oral/pharyngeal cancer mortality.
December 9, 2012
Previous Page
Page 58 of 116
Next Page